Перевести на Переведено сервисом «Яндекс.Перевод»

Acura Pharmaceuticals

Страна
USA
Краткое название
Acura Pharmaceuticals
Штаб квартира
616 N. North Court Suite 120
Члены правления

Robert B. Jones,
President & Chief Executive Officer
Peter A. Clemens,
Senior Vice President, Chief Financial Officer
James F. Emigh R.PH.,
Vice President, Corporate Development
Robert A. Seiser CPA,
Vice President, Treasurer and Corporate Controller
Albert W. Brzeczko Ph.D.,
Vice President, Technical Affairs
J. Bradley Rivet,
Vice President, Marketing
Ronald L. Leech,
Senior Director Quality & Analytical Chemistry
John G. Gilkay P.E.,
Director of EHS & Engineering
Gregory A. Spinner,
Director of Logistics and Special Projects

Разделы медицины
Терапия
Стадия проекта
Производство
Заболевания
Метаболический синдром
Тикер
ACUR
Текущие владельцы

Robert B. Jones,
President & Chief Executive Officer
George Ross,
Early Stage Business Consultant
William G. Skelly,
President and Chief Executive Officer, Central Biomedia, Inc.
Immanuel Thangaraj,
Managing Director and General Partner, Essex Woodlands Health Ventures
Bruce F. ,Toby, Wesson,
Founder, Senior Advisor; Galen Partners

Объем фонда
49.2100
Технологии
Сервисы, Технологии, Фармацевтика, Химия